Aramark director credited dividend equivalent rights in Form 4
Aramark reported a routine insider equity update for a director.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Aramark reported a routine insider equity update for a director. On 12/17/2025, the reporting person received 96.688 shares of common stock as dividend equivalent rights tied to deferred stock units, at a stated price of $0 per share. These dividend equivalent rights vest on the same schedules as the underlying awards. After this transaction, the reporting person beneficially owned 30,513.088 shares of Aramark common stock in direct ownership.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 96.688 | $0.00 | $0.00 |
Footnotes (1)
- F1. Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Aramark (ARMK) disclose in this Form 4?
What is the nature of the dividend equivalent rights reported for Aramark (ARMK)?
What is the relationship of the reporting person to Aramark (ARMK)?
AI-generated analysis. How Rhea-AI works. Not financial advice.